Although these mutations were found in all IPMN subtypes, GNAS mutations were more prevalent in the intestinal subtype, whereas KRAS mutations were more prevalent in the pancreatobiliary subtype [70–72]. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.